Free tool
Stocks listed on ASX
We cover 50 companies listed on ASX. The median market value in the group is $518.87M. Across the group, the median move over the past trading day is 0.00%. 49% of the 49 with a 200-day average trade above it. Price change over the past year runs from −39.2% to +111.5% across the middle 80 percent of the group, with a median of +0.7%.
Other lists in this group
Table
50 of 1,792 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.75% |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +1.45% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.88B | Small cap | +5.54% |
| PYC.AX | PYC Therapeutics Limited | $1.60B | Small cap | +74.42% |
| 4DX.AX | 4DMedical Limited | $1.59B | Small cap | +669.79% |
| REG.AX | Regis Healthcare Limited | $1.32B | Small cap | −20.05% |
| RYM.AX | RYM FPO NZX [RYM] | $1.27B | Small cap | −27.80% |
| SNZ.AX | Summerset Group Holdings Limited | $1.22B | Small cap | −26.63% |
| AVR.AX | Anteris Technologies Global Corp. | $861.47M | Small cap | +106.39% |
| EIQ.AX | Echo IQ Limited | $814.45M | Small cap | +609.30% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −19.60% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $628.73M | Small cap | −25.63% |
| NAN.AX | Nanosonics Limited | $577.84M | Small cap | −39.91% |
| AYA.AX | Artrya Limited | $539.15M | Small cap | +157.95% |
| IMR.AX | Imricor Medical Systems, Inc. | $498.58M | Small cap | +40.43% |
| PNV.AX | PolyNovo Limited | $485.11M | Small cap | −23.99% |
| CGS.AX | Cogstate Limited | $376.22M | Small cap | +85.76% |
| ACL.AX | Australian Clinical Labs Limited | $373.98M | Small cap | +5.46% |
| OCA.AX | Oceania Healthcare Limited | $342.58M | Small cap | +9.17% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $338.48M | Small cap | −24.94% |
| AVH.AX | AVITA Medical, Inc. | $324.65M | Small cap | +106.12% |
| RAC.AX | Racura Oncology Ltd | $312.81M | Small cap | +87.39% |
| AFP.AX | AFT Pharmaceuticals Limited | $278.02M | Small cap | +50.00% |
| SPL.AX | Starpharma Holdings Limited | $248.56M | Small cap | +437.04% |
| TTX.AX | Tetratherix Limited | $245.18M | Small cap | +56.83% |
| HLS.AX | Healius Limited | $233.27M | Small cap | −50.55% |
| MVF.AX | Monash IVF Group Limited | $192.37M | Small cap | +0.35% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +60.00% |
| MYX.AX | Mayne Pharma Group Limited | $182.17M | Small cap | −37.38% |
| PGC.AX | Paragon Care Limited | $166.54M | Small cap | −58.24% |
| EBR.AX | EBR Systems, Inc. | $154.30M | Small cap | −78.74% |
| OCC.AX | Orthocell Limited | $148.74M | Small cap | −36.67% |
| ARX.AX | Aroa Biosurgery Limited | $140.72M | Small cap | −13.85% |
| NYR.AX | Nyrada Inc. | $135.23M | Small cap | +210.20% |
| DXB.AX | Dimerix Limited | $122.97M | Small cap | −34.83% |
| ONE.AX | Oneview Healthcare PLC | $120.16M | Small cap | −15.56% |
| EMV.AX | EMVision Medical Devices Ltd | $119.89M | Small cap | −13.93% |
| SDI.AX | SDI Ltd | $119.34M | Small cap | +60.41% |
| ACW.AX | Actinogen Medical Limited | $117.55M | Small cap | +44.83% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.